SpitzerWOSuissaSErnstPHorwitzRIHabbickBCockcroftD. The use of β-agonists and the risk of death or near death from asthma. N Engl J Med1992; 326: 501–6.
2.
Fully halogenated chlorofluorocarbons. International Programmes on Chemical Safety. Environmental health criteria 113. Geneva: World Health Organization, 1990: 89–95.
3.
ValicFSkuricZBanticZRudarMHecejM. Effects of fluorocarbon propellants on respiratory flow and ECG. Br J Ind Med1977; 34: 130–6.
4.
Graff-LonnevigV. Diurnal expiratory flow after inhalation of freons and fenoterol in childhood asthma. J Allergy Clin Immunol1979; 64: 534–8.
5.
YarbroughJMansfieldLETingS. Metered-dose inhaler-induced bronchospasm in asthmatic patients. Ann Allergy1985; 55: 25–7.
6.
AhlströmHSvenoniusESvenssonM. Treatment of asthma in preschool children with inhalation of terbutaline in Turbuhaler compared with Nebuhaler. Allergy1989; 44: 515–8.
7.
NewmanSPMorénFTrofastETalaeeNClarkeSW. Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. Eur Respir J1989; 2: 247–52.